Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Riluzole has been approved for treatment of patients with amyotrophic lateral sclerosis in many countries but not all. Questions persist about its clinical utility because of high cost, modest efficacy and concern over adverse effects.